Esperion Therapeutics | ESPR - Acreedores Comerciales

Precio De Mercado
2.78
Cambio Diario
0.16 5.92%
Mensual
-17.41%
Anual
70.25%
Q1 Expectativa
2.47




Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amarin USD 45.36M 8.64M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cipla INR 30.35B 1.98B 2025-09
CSL USD 3.17B 290M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Geron USD 11.26M 146K 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12